What is the risk of placenta accreta in a nulligravid woman with a history of myomectomy with entry into the endometrial cavity?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: January 8, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Risk of Placenta Accreta After Myomectomy with Endometrial Cavity Entry

A. Increase - The risk of placenta accreta is definitively increased when the endometrial cavity is entered during myomectomy, as this creates a disruption of the endometrial-myometrial interface that damages the normal decidualization process and allows abnormally deep placental anchoring in future pregnancies. 1, 2

Pathophysiologic Mechanism

The American College of Obstetricians and Gynecologists explains that placenta accreta spectrum develops through a specific mechanism: defects in the endometrial-myometrial interface lead to failure of normal decidualization in areas of uterine scarring, which allows abnormally deep placental anchoring villi and trophoblast infiltration. 3, 1, 2

Entry into the endometrial cavity during myomectomy creates precisely this type of pathologic disruption. When the surgeon enters the endometrial cavity, this creates a full-thickness defect that damages the endometrial-myometrial interface and affects scar tissue development—the exact mechanism that increases placenta accreta likelihood. 1 This is particularly significant because it creates a defect similar to cesarean delivery rather than a subserosal defect that would not involve the decidual layer. 1

Established Risk Factor Status

Prior uterine surgeries, including myomectomy, are explicitly listed as established risk factors for placenta accreta spectrum by the American College of Obstetricians and Gynecologists. 1, 4 This places myomectomy in the same category as cesarean delivery, curettage, and Asherman syndrome as recognized causes of accreta. 1

Multiple case reports and series document placenta accreta occurring at myomectomy sites, particularly when the placenta overlies the surgical scar in subsequent pregnancies. 5, 6 One case series specifically documented placenta increta after hysteroscopic myomectomy, emphasizing that any uterine leiomyoma treatment carries increased risk for abnormal placentation. 6

Risk Magnitude and Clinical Context

The absolute magnitude of risk after myomectomy with cavity entry is not as precisely quantified as it is for cesarean delivery, where systematic data shows 3% baseline risk with placenta previa alone, escalating to 11% after one cesarean, 40% after three, and 67% after five or more cesarean deliveries. 3, 1 However, the pathophysiologic mechanism is identical. 1, 2, 7

The risk escalates dramatically if placenta previa develops overlying the myomectomy scar—similar to the well-established cesarean scar-previa combination that creates the highest accreta risk. 1 This represents the highest-risk scenario requiring intensive surveillance. 1

Clinical Implications for Future Pregnancies

Surveillance Requirements

  • All future pregnancies require careful ultrasound evaluation for placenta location relative to the myomectomy scar site. 1, 5
  • If the placenta overlies any uterine abnormality or surgical scar, a meticulous search for invasive placentation is warranted. 5
  • Gray-scale ultrasound should assess for loss of the normal hypoechoic retroplacental zone, multiple placental lacunae, retroplacental myometrial thickness <1mm, and abnormalities of the uterine serosa-bladder interface. 1, 8
  • Color Doppler imaging should evaluate for turbulent lacunar blood flow, increased subplacental vascularity, and vessels bridging the placenta to the uterine margin. 1, 8

Delivery Planning

  • Women with suspected placenta accreta spectrum should be referred to a level III or IV maternal care facility with multidisciplinary expertise for delivery planning. 1, 8, 2
  • Planned delivery at 34 0/7 to 35 6/7 weeks gestation optimizes outcomes in stable patients with confirmed accreta. 8
  • The most accepted approach is cesarean hysterectomy with placenta left in situ, as attempts at placental removal are associated with significant hemorrhage risk. 2

Important Caveats

The absence of ultrasound findings does not preclude a diagnosis of placenta accreta spectrum—clinical risk factors (including history of myomectomy with cavity entry) remain equally important as predictors even when imaging appears normal. 2 This patient's surgical history alone mandates heightened vigilance regardless of imaging findings.

References

Guideline

Risk of Placenta Accreta After Myomectomy with Endometrial Cavity Entry

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

[Placenta accreta: screening, management and complications].

Gynecologie, obstetrique & fertilite, 2013

Research

Placenta accreta: an association with fibroids and Asherman syndrome.

Journal of ultrasound in medicine : official journal of the American Institute of Ultrasound in Medicine, 2008

Research

Placenta increta after hysteroscopic myomectomy.

Obstetrics and gynecology, 2013

Research

New insights into the etiopathology of placenta accreta spectrum.

American journal of obstetrics and gynecology, 2022

Guideline

Diagnostic Ultrasound Findings for Placenta Accreta Spectrum

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.